Epidemiologic data, early

Epidemiologic data show that 10% to 30% of patients with schizophrenia develop their first psychotic symptoms prior to their eighteenth birthday. Onset between puberty and age of 18 is sometimes classified as early-onset schizophrenia (EOS) or intermediate onset schizophrenia, and those presenting with symptoms before puberty are classified as very early-onset... 

As the therapy of AMD is very limited, there is an urgent need to develop an intervention to prevent vision loss. The epidemiological data together with the well-documented antioxidant properties of carotenoids in studies in vitro and with proven increases in macular pigment density in most people via dietary supplementation (Beatty et al., 2004 Berendschot et al., 2000 Bone et al., 2003 Hammond et al., 1997 Iannaccone et al., 2007 Landrum et al., 1997), including patients with early AMD (Koh et al., 2004 Obana et al., 2008 Richer et al., 2007 Trieschmann... 

An important implication of this observation is the suggestion that early intervention in schizophrenia could substantially alter the natural course of the illness. To investigate this idea, early-intervention projects have been developed. In one, primary physicians were trained to recognize the early symptoms of a mental disorder and to arrange consultation with an intervention team who assessed and treated the disorder. If early symptoms were present, the functional psychotic disorder was treated with low doses of the appropriate medication, often for a relatively short period of time (i.e., several weeks), and then tapered when symptoms abated while psychosocial intervention was continued. In some patients, symptoms returned and medication was reinstituted. The psychosocial program, social skills training, and social casework were continued for some time, and all patients were monitored for at least 2 years. Epidemiological data established that over the lifetime of this project, 7.5 new cases would be expected for 100,000 patients (227, 228). 

Early epidemiological data on the recurrence of thrombosis (44) indicated something of an inherited predisposition, and others found a low content of fibrinolytic activators in the vessel wall of women who 6-12 months earlier had experienced a thrombotic complication while using oral contraceptives (45) high doses of estrogen affected the concentrations of such activators (46). However, such lesions are apparently not exclusive to users of oral contraceptives (SEDA-8,360) and examination of the vessel wall is not of predictive value in determining risk. 

Many cases of mild bacterial conjunctivitis are self-limiting and resolve without treatment. However, antibiotic therapy often lessens the patient s anxiety and ocular symptoms, shortens the duration of the disease, and prevents recurrence or spread to the fellow eye. Contagion is also a significant risk. Several severe bacterial conjunctivitis outbreaks have been reported. Among the more common requests in ophthalmic practice are releases permitting patients who had conjunctivitis to return to work or school. Epidemiologic data support the clinical and public health benefits of early treatment. 

Infants can be exposed to substantial amounts of Epidemiological data on the impact of chronic phenolics and colonization events determine the early exposure to phenolics are warranted and metabolic potential of intestinal microbiota effort should be put in characterizing the establishment of intestinal microbiota in large ... 

To conclude, there may be an increased risk of malformations if oral contraceptives are given in early pregnancy. However, more epidemiological data are needed before any conclusions concerning risk figures can be made. If pregnancy follows cessation of medication, there appears to be no extra risk of malformations. 

Effective surveillance and monitoring systems have been developed to generate epidemiological data about the presence or absence of diseases and their prevalence. Such systems provide vital information about the spread of diseases that can be used in the control and containment of hazards (e.g. pathogens) or the demonstration of freedom from disease status. In fact, the analysis of surveillance data can produce early warning indicators and trends in disease patterns that can support the need for biosecurity contingency plans, such as import controls or the establishment of buffer zones. 

Sullivan FM, Barlow SM. 1985. The relevance for man of animal data on reproductive toxicity of industrial chemicals. Prevention of Physical and Mental Congenital Defects, Part B Epidemiology, Early Detection and Therapy, and Environmental Factors. Alan R. Liss, Inc. 

---